论文部分内容阅读
自1982年以来,我们与吉林农大协作采用丙硫咪唑治疗人囊虫病,临床收到显著效果。1984年对丙硫咪唑治疗人囊虫病的临床观察,经国内21名知名专家学者鉴定,一致认为,丙硫咪唑治疗人囊虫病是国内首创,国外尚无报道。现将经过我院治疗后出院半年并随访的130例临床疗效观察报告如下:临床资料 1.收治对象 130例中男112人,女18人;年龄14～65岁,20岁以下者9人,21～45岁90人,46岁以上者31人;病程最短1个月,最长15年;接受过吡喹酮、囊虫丸、羊角散、千金丸和其它药物治疗的111例,其中有服吡喹酮达672片(每片200mg)的1例;服用囊虫丸14年的1例。未接受任何药物
Since 1982, we collaborated with Jilin Agricultural University in the use of albendazole to treat human cysticercosis and clinically received significant results. Cefazolin in 1984 for the treatment of human clinical observation of cysticercosis, the domestic 21 well-known experts and scholars identified, agreed that cetirizazole in the treatment of human cysticercosis is the first domestic, there are no reports abroad. Now after hospital discharge of six months and follow-up clinical observation of 130 cases were as follows: Clinical data 1. The object of treatment 130 cases of male 112, female 18; aged 14 to 65 years, 9 were under 20 years of age, 21 to 45 years old and 90 people, 46 people over the age of 31; shortest duration of 1 month, up to 15 years; received praziquantel, cysticercosis pill, claw powder, daughter pills and other drugs in 111 cases, of which service Praziquantel 672 tablets (200mg per tablet) in 1 case; taking cysticercosis pill in 14 cases in 1 case. Did not receive any medication